期刊文献+

临床药师参与236例感染性病例的会诊分析 被引量:5

Participation of clinical pharmacists in consultation on 236 cases of infectious diseases
在线阅读 下载PDF
导出
摘要 目的了解临床药师参与感染性疾病会诊病例特点,探讨多重耐药及泛耐药细菌感染的特点及治疗策略。方法回顾性分析236例感染性病例的资料,按照性别、年龄、高危感染因素、病原菌及其耐药情况、治疗结果等进行统计分析。结果会诊患者年龄分布中60岁以上老年人的比例占63.98%,会诊意见总体被采纳情况较好(总体接受率占99.15%),多重耐药细菌(MDR)、广泛耐药细菌(XDR)、泛耐药细菌(PDR)总体治疗效果较好,总有效率为78.05%。结论临床药师通过参与感染性病例的会诊,在为患者进行抗感染治疗方案的制定和患者病情的转归方面发挥了重要作用。 Objective To study the characteristics of consultation on infectious diseases that clinical pharmacists participated in and to discuss the characteristics and treatment strategies of MDR/XDR/PDR bacterial infection. Methods All the infectious disease 236 cases that clinical pharmacists took part in were enrolled. All the data were analyzed as to gender,age,risk factors,pathogenic bacteria,their drug resistance and the outcomes et al. Results In this study,the age more than sixty years old was 63. 98%. The accepted of clinical pharmacists' suggestions was very good( the overall acceptance ratio was 99. 15%). The treatment result of MDR/XDR/PDR is 78. 05%. Conclusion Clinical pharmacist participating in therapy for bacteria infection have been achieved good therapeutic efficacy.Reflects clinical pharmacists have played an important role in anti-infection drug treatment and prognosis of hospitalized patients.
出处 《安徽医药》 CAS 2017年第10期1930-1933,共4页 Anhui Medical and Pharmaceutical Journal
关键词 临床药师 多重耐药菌 会诊 抗菌药物 Clinical pharmacist Multidrug-resistant bacteria Consultation Antibiotics
  • 相关文献

参考文献6

二级参考文献57

  • 1刘力生.中国高血压防治指南2010[J].中国医学前沿杂志(电子版),2011,3(5):42-93. 被引量:1235
  • 2汤韧,刘祖雄.微生态制剂治疗儿童肠道疾病的研究进展[J].医药导报,2005,24(8):657-659. 被引量:2
  • 3魏全珍,钟馥霞,刘丽华,张惠珍.超广谱β-内酰胺酶细菌检测及耐药性分析[J].中华医院感染学杂志,2006,16(2):221-223. 被引量:42
  • 4金有豫,高润霖.中国国家处方集[M].北京:人民军医出版社,2010.
  • 5Magiorakos A P, Srinivasan A, Carey R B, et al. Multidrug- resistant (MDR), extensively drug-resistant (XDR) and pan drug-resistant (PDR) bacteria in healthcare settings. Expert proposal for a standardized international terminology [ EB/ OL]. (2010-08). ECDC Entwurf 2010 . www. escmid, org.
  • 6耐万古霉素肠球菌感染防治专家委员会. 耐万古霉素肠球菌感染防控专家共识[J]. 中华实验和临床感染病杂志,2012,4(2):224-231.
  • 7国家卫生部;国家中医药管理局;总后勤部卫生部.医疗机构药事管理规定[S],2011.
  • 8国家卫生部.抗菌药物临床应用管理办法[Z],2012.
  • 9Magiorakos AP, Srinivasan A, Carey RB,et al. Muhidrug-resistant, extensively drug-resistant and pandurg-resisitant bacteria:an inter- national expert proposal for interim standard definitions for acquired resistance E J]. Clin Mierobiol Infect, 2012, 18 ( 3 ) : 268-281.
  • 10Lim LM, Ly N, Anderson D,et al. Resurgence of colistin:a reviewof resistance, toxicity, pharmacodynamics, and dosing [ J ]. Pharma- cotherapy,2010,30 (12) : 1279-1291.

共引文献108

同被引文献53

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部